Nonsteroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Mechanistic Basis, Clinical Evidence, and Therapeutic Integration
The therapeutic landscape for heart failure (HF), particularly in patients with mildly reduced (HFmrEF) and preserved ejection fraction (HFpEF), has historically been characterized by limited effective disease-modifying options. The recent approval of nonsteroidal mineralocorticoid receptor antagoni...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2026-05-01
|
| Серія: | Drugs and Drug Candidates |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/2813-2998/5/2/33 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|